A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). B Animal ...

The prescribing of antiviral drugs for US children and adolescents receiving treatment for influenza was less than 60% in the ...

Emerging data suggest that antiviral therapy in the third trimester can prevent immunoprophylaxis failure. To minimize fetal exposure to antiviral agents, antiviral therapy during pregnancy should ...

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

A new study conducted by the Hepatitis Research Group at the Medical Research Council Unit The Gambia at the London School of ...

The frequency and severity of your recurrences are also considered. In people with recurrent herpes, antivirals can be given daily to prevent outbreaks (referred to as prophylactic therapy). Keeping ...

All-cause mortality risk did not significantly differ by HIV coinfection status in patients with chronic hepatitis C infection and advanced liver fibrosis who achieved sustained virologic response ...

Business which accounts for close to one-third of group sales also took in €437m in dividends from subsidiaries dotted ...

SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30 ...

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, ...

NanoViricides (NYSE American: NNVC) will present a corporate update at the Spartan Capital Investors <a target=_blank href= ...

Hepatitis C virus (HCV) is the major cause of liver disease worldwide and a potential source of high morbidity and mortality in the future. The World Health Organization estimates that ...